University Hospital Waterford, formerly known as Waterford Regional Hospital, is a teaching hospital located in Waterford, County Waterford, Ireland. It is managed by South/Southwest Hospital Group.

There are 429 beds in Waterford Regional Hospital.

During the past decade, Waterford Regional Hospital conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 18 clinical trials were completed, i.e. on average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 10 clinical trials were completed. i.e. 62.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Waterford Regional Hospital" #1 sponsor was "Cancer Trials Ireland" with 27 trials, followed by "Hoffmann-La Roche" with 5 trials sponsored, "National Cancer Institute (NCI)" with 5 trials sponsored, "Incyte Corporation" with 4 trials sponsored and "ETOP IBCSG Partners Foundation" with 4 trials sponsored. Other sponsors include 30 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Waterford Regional Hospital" #1 collaborator was "Cancer Trials Ireland" with 5 trials as a collaborator, "Merck Sharp & Dohme LLC" with 4 trials as a collaborator, "Breast International Group" with 3 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 72 different institutions and companies that were collaborators in the rest 71 trials.

According to Clinical.Site data, the most researched conditions in "Waterford Regional Hospital" are "Breast Cancer" (11 trials), "Colorectal Cancer" (5 trials), "Breast Neoplasms" (3 trials), "Cancer" (3 trials) and "Chronic Lymphocytic Leukemia" (3 trials). Many other conditions were trialed in "Waterford Regional Hospital" in a lesser frequency.

Most popular intervention types in "Waterford Regional Hospital" are "Drug" (50 trials), "Other" (15 trials), "Biological" (12 trials), "Procedure" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Pembrolizumab" (6 trials), "Placebo" (6 trials), "Carboplatin" (5 trials), "Docetaxel" (4 trials) and "Laboratory Biomarker Analysis" (4 trials). Other intervention names were less common.

The vast majority of trials in "Waterford Regional Hospital" are 47 trials for "All" genders, 27 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Waterford Regional Hospital". undefined are not yet recruiting, 9 are recruiting, 26 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Waterford Regional Hospital, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Waterford Regional Hospital, 2 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".